Redcliffe Labs Affordable Diagnostics Makes Remarkable $400Million Positive Impact on Economic Savings of India

As per the breakthrough research released at the 78th UN General Assembly week, Redcliffe Labs, together with Leapfrog Investments, proudly unveils a remarkable achievement in healthcare. Our diagnostic tests are not just a benchmark of high-quality tests; they are cost-effective solutions that potentially transform healthcare dynamics in India. So far, Redcliffe Labs, with the digitally first approach and affordable diagnostic services, has delivered $400M in economic savings for India.

Need for The Cost-Effective Healthcare Solution:

India faces an alarming economic loss estimated at $3.6 trillion due to non-communicable diseases (NCDs) between 2012 and 2030. It's a staggering figure but also a call for innovative healthcare solutions to mitigate this looming crisis.

Redcliffe Labs’ Contribution to Health and Economy:

Through rigorous research supported by LeapFrog Investments, we have uncovered that – Redcliffe Labs' diagnostic tests are exceptionally cost-effective in combatting prevalent illnesses like diabetes and heart disease, surpassing many conventional treatments. Our tests have proven to be up to 8 times more cost-effective in preventing cardiovascular disease consequences compared to national treatment coverage. Additionally, our diabetes tests cost less than 2/3 of comparable screening and telemedicine interventions*.

The Power of Affordability and Convenience

At Redcliffe Labs, we are driven by a mission to make healthcare accessible to all. We have achieved this through a nationwide network of pathology labs, digital booking systems, and at-home phlebotomy services. These innovations have made us one of India's most cost-effective providers of vital tests for diabetes, thyroid, heart risk markers, and all other health checkups addressing illness or ensuring wellness.

Today, we serve in more than 220 cities nationwide with 80+ labs and 2000+ authorized collection centers with over 40% NABL-recognized labs. We have been making significant efforts for the economic savings of the country, but it does not end here. We are continuously progressive in enhancing healthcare scenarios and affordability with a vision of a Healthier Bharat. 

Better Health of Nation- A Collective Responsibility

In the face of the growing burden of non-communicable diseases (NCDs), both public and private healthcare providers have critical roles to play. It's not just about extending the reach of diagnostics; it's about driving innovations that reduce costs and enhance convenience.

The impact of our efforts transcends numbers and statistics. It's about empowering individuals to monitor and track their health, protecting their well-being, and boosting their prosperity. Our journey has just begun. Redcliffe Labs is committed to accelerating its impact in the coming years. We envision a future where healthcare is not just a service but a fundamental right accessible to all. 

Diagnostics is the Key to Healthcare Transformation- Dr. Sohini Sengupta, Medical Laboratory Director, Redcliffe Labs

Redcliffe Labs’ focus on affordable and convenient diagnostic services is a frontline defence against India's growing epidemic of non-communicable diseases. By slashing costs and improving convenience, Redcliffe has already delivered almost half a billion dollars in economic savings for India, and we plan to accelerate this impact in the coming years.

“This research shows the growing role diagnostics plays in lowering healthcare costs and empowering consumers to monitor and track their health to protect their well-being and boost their prosperity. It’s not just about how many patients you reach but how profoundly you impact their lives and the broader community.”

Innovation in Healthcare is Critical for India’s Economic Future- Biju Mohandas, Partner and Global Co-Leader for Healthcare Investments at LeapFrog Investments

This research shows the critical importance of innovation in healthcare for India’s economic future. Impact investing in healthcare has long focused on reach and volume metrics. Still, this new data digs deeper to quantify economic effects and deliver comparative analysis across the whole healthcare ecosystem.”

“What the results demonstrate is startling, and for impact investors show that what is a fast-growing and profitable sector is also delivering immense and transformative social impact.”